FC
AMGN icon

Fairscale Capital’s Amgen AMGN Stock Holding History

Fairscale Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Sell
310
-649
-68% -$222K 0.07% 142
2026
Q1 		$337K Hold
959
– – 0.23% 68
2025
Q4 		$314K Hold
959
– – 0.21% 69
2025
Q3 		$271K Hold
959
– – 0.19% 75
2025
Q2 		$283K Hold
959
– – 0.21% 71
2025
Q1 		$299K Hold
959
– – 0.27% 56
2024
Q4 		$250K Hold
959
– – 0.22% 65
2024
Q3 		$309K Hold
959
– – 0.27% 57
2024
Q2 		$319K Buy
+959
New +$282K 0.28% 59

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fairscale Capital's AMGN Position: Q2 2026 in Review

Fairscale Capital reduced its Amgen (AMGN) stake by 68% in Q2 2026, selling an estimated $222K and leaving 310 shares worth $112K. The position accounts for 0.07% of the portfolio, ranked #142.

Fairscale Capital first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $337K in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fairscale Capital held 310 shares of Amgen worth $112K as of Q2 2026.
  • Fairscale Capital sold 649 Amgen shares in Q2 2026, an estimated $222K.
  • Amgen made up 0.07% of Fairscale Capital's portfolio in Q2 2026, its #142 holding.
  • Fairscale Capital first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • Fairscale Capital's Amgen position peaked at $337K in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.